{"name":"Bionovo","slug":"bionovo","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":2058000,"revenueGrowth":676.6,"grossMargin":0,"rdSpend":74876000,"netIncome":-87245000,"cash":18458000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2011"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"BZL101","genericName":"BZL101","slug":"bzl101","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"BZL101","genericName":"BZL101","slug":"bzl101","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxPOUNkS2thbml6ZThGVjNlTTViVmw2TVhBTGtkdXZ1ZFNXYmRmVllTdUxHQ0pLUF9BdVFCQVJ3Y3VfNDFWN3lVMWlGcjE3Q2ZGQzRtaXNJWWlNcFg5RUlLdi1xVTlMVDljcG5oazIwNGpUVDJLaFVDNUdxRFlEUmF3Qm4ybDZPOXpKZ0FpdkYycnU?oc=5","date":"2026-02-12","type":"pipeline","source":"Medical Marketing and Media","summary":"The Escalator: CSL, Braveheart Bio, Novo Nordisk and more - Medical Marketing and Media","headline":"The Escalator: CSL, Braveheart Bio, Novo Nordisk and more","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxOclU4M2NHQUlFMmJyYTBlb3M1NDFJR2pyYzFMSURPV1gtZ0ZRRWVsQThhOGVDay1ZT29sbWwxNkR3Z3dqUEtqa3hnUW4zVEljMmZ5V2dnZmJxQjZEOVpZb1NsZW5RWmhQeWVPY2dBVXhkbkFURnRKb3ZpVk03RnBUcG44RDBVbml2bDhFeFZzNnRQdy1LbDdsT2RxQmxiN2s2NkV3c092dGtiR0JQ?oc=5","date":"2025-11-13","type":"pipeline","source":"Fierce Biotech","summary":"Korro lays off 34% of staff as lead drug disappoints and Novo Nordisk pauses pact - Fierce Biotech","headline":"Korro lays off 34% of staff as lead drug disappoints and Novo Nordisk pauses pact","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxObHAtSC1WcUZGRU5wbEZuRjV6bEt1Z0xWQklNdjc5R294eXVFc3dCRm5waUdhR2R4QWZ6TW11SE5MUnV0VnlnbDI3U0c4djVHYzY2N3N5d25yWVJ3RFp1SjdDdEdELWRoZjZMa20tbEIyV1FnU001cXpQMXI0NkZDbk1sMDZybGl3WEV1d202VU1pOVdUeWJGNVF5aHlINjg?oc=5","date":"2025-01-07","type":"earnings","source":"The New York Times","summary":"Drug Company to Share Revenues With Indigenous People Who Donated Their Genes (Published 2025) - The New York Times","headline":"Drug Company to Share Revenues With Indigenous People Who Donated Their Genes (Published 2025)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgJBVV95cUxQbVljYkFaZnNTTVRFZHc0aGx6UFZDckJWd1llVG5qMHlhcGxCWURKeUlnMGE4Xzd0YVJBUDlBdUZjNFNLbFRXVHY1XzJ5STZ3c2xCTnBfS2Z1aHVSS3d1NG5rTWszRGZnZ1huMVdsMmdZNGpNQjZJMFBkVmN4M1ZTUm5xY245TzFDR2ZFUjltT3VLQUhJUU1ycDdJY1FUMmd3SHNsZW9wWktNUGFMeTB2T010N2d0QURNcElwYzN2UWxDVWNmQ3hjNGhDLVZkdjc4ekFjczhMYl8xcTF3Qm9ZWGUzdmdHSFA2RHBFQlJCYmN2aXZ1UXQtQ0c3eGk4Vjk5T1pYTjVB?oc=5","date":"2025-01-07","type":"deal","source":"PR Newswire","summary":"Variant Bio Announces Multi-Year Research Partnership with Novo Nordisk to Discover Novel Targets for Metabolic Disease - PR Newswire","headline":"Variant Bio Announces Multi-Year Research Partnership with Novo Nordisk to Discover Novel Targets for Metabolic Disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwJBVV95cUxNX0YwemhHT3pCa2lNeHJ4MTRDOXViREs0UW51Qk02aE9oN1pkUkJRVUdpdGFjRE5tczRMdENHWmRVNndzSWFHeUVhV2hTZnoydmFTSnBRa2FYWEJVR0RpWlRISHlEQVRCSXd4MWRvNjZ0Tmt3T2dRZnhFYjNNT2U4M3hHcXBUMl9QekduU2lGd2tZbFBkVVJTOURfSmRqQ2lHOW9KWC01RzlGYjI1bVBjeThpbTV6X2hKZm4xb092QllGemdVdllaem1mb3hyeEdCN0pGek5YcHpfLURfeElsVEpxRi0zclRFY001WEFaT3VoQldZUUJydUdpWGR1d3lhMWUtc3o4RThsMDE1MlBIQXZoSDlhbVVVcElERERSNA?oc=5","date":"2024-06-26","type":"pipeline","source":"Business Wire","summary":"2seventy bio Announces Sale of Hemophilia A Candidate and MegaTAL In Vivo Gene Editing Technology to Novo Nordisk for up to $40 million - Business Wire","headline":"2seventy bio Announces Sale of Hemophilia A Candidate and MegaTAL In Vivo Gene Editing Technology to Novo Nordisk for up","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxQQm9PMFR5dmE4OHpJazZ1VXlCZVpCX2ppbktMMkdva1I0cUNNQUhQRGdZZlZQVkdKcmtGM2RBTlJmVXplNnVJejVnaUhoN2I2dXBDbXoyYXg5cm1VeHlHSlV1S2ZVRl9iQXIxTjk1SUd3UC1IUHl3VDBnTUh3bHMyWHlMbm5sN2dfUzZJVzY5eEtVV2VGeWxiUzRfcVFPUnB6cG95Sk9kUTV5czkyV2NfMVJSOEhEOXpuWE9V?oc=5","date":"2024-06-26","type":"pipeline","source":"Fierce Biotech","summary":"2seventy bio divests again, this time sending hemophilia and gene editing science to Novo Nordisk - Fierce Biotech","headline":"2seventy bio divests again, this time sending hemophilia and gene editing science to Novo Nordisk","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxNc2RhaTRnbkN4dmJFWEs1RHlIYmQ3aEY3S09zYks1dVRmZ2sxQm13YlpjQkZOSmxRNmJadWhVZ0tQWWNZUjZZM3hFa1hzdlVHeW5EbDdzNEVyMkMzcWFvNHhEUTdUckhRYTVTcUg2ZG01R0lLWXJMRVVWQ2psYWluT3pES0ZidDlHZ3FfSVktbWhkcG10dFRpSXJvNUMwd2xjZ0ZZcVFXdGhaak1FNEp0U01Scw?oc=5","date":"2024-06-05","type":"deal","source":"MedCity News","summary":"At BIO, Novo Nordisk’s Top Dealmaker Talks M&A Strategy and What’s Next After GLP-1s - MedCity News","headline":"At BIO, Novo Nordisk’s Top Dealmaker Talks M&A Strategy and What’s Next After GLP-1s","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxPZlNkUFlDeEY1b1otVG1UeEpZeHE2VWVVcmlhVXVpS1hQbE1fd3dwNlhVX0dtVWlUSnExRWd5Nm5ON3ZEMjItNmZCUWdwbEJMRTZ4UnRjOWdZUXFXS0R5OGdTSGdVTW9fZWh2RkhxNjc4M1lqbGJnMy03X3RiM1YxOWFhNTJETzhIYlZaeS1YNFh5NjZUbTUyaWZINmlDdjl3RDU1cDcxYzhNZzNhWVk1YUc5UWJrMG04NDFXVWRoQTBDQQ?oc=5","date":"2022-01-10","type":"pipeline","source":"Fierce Pharma","summary":"2seventy brings in Genevant delivery tech for Novo Nordisk in vivo gene editing project - Fierce Pharma","headline":"2seventy brings in Genevant delivery tech for Novo Nordisk in vivo gene editing project","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPdUt1UmNRd1F3WTJTQmFZQVJCUDFNNnlROFZWajdraHg3cG9lSklyY21jaHZla2w1bUFzenNsS1NwdXl0YkZuU0h4R3NkblA0ZnNrcjNmZ3psaTJVRUlSMHluVFRoclloc05ldG9RZXBEQTdqVUpJTXZzMEdLbXJNN0lHVVFiWmZoYnBLclhmdVo0MzRUOERsd3pVREItcmhkREE?oc=5","date":"2020-07-16","type":"pipeline","source":"Fierce Pharma","summary":"Bionova aims to launch commercial manufacturing by 2021 with new biologics plant - Fierce Pharma","headline":"Bionova aims to launch commercial manufacturing by 2021 with new biologics plant","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTE91LUpkb0FOUnBjV0diY3RwUW1MMmFxZ2tRUzdfYk5oVUZUUThSUENTZWc3MURJOWlEYzdCdi1YeV91ZVpqTUlBUWtad2hycUpFQVQ4ckhDT1BOLWtqNHdHSERR?oc=5","date":"2016-01-13","type":"pipeline","source":"businessnews.com.au","summary":"Louis Drapeau - businessnews.com.au","headline":"Louis Drapeau","sentiment":"neutral"},{"date":"2012-11-01","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2012-05-25","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2012-05-15","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2012-05-08","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"date":"2012-04-27","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar","revenue":2058000,"revenuePeriod":"2011-12-31","revenueHistory":[{"value":2058000,"period":"2011-12-31"},{"value":265000,"period":"2011-12-31"},{"value":613000,"period":"2010-12-31"},{"value":288000,"period":"2009-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":74876000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-87245000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":18458000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"ciks":null,"lastFiledAt":null},"yahoo":null}